Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07201194 | Holistic Acupuncture for Patients With Chemotherapy Induced Nausea | recruiting | N/A | 90 | Vejle HospitalOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT06904625 | Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer(CAPT CTC) | recruiting | N/A | 54 | Institut Claudius RegaudOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT07607990 | Effects of Rectal Indomethacin Suppository on Postoperative CRBD in Patients Undergoing LRP | recruiting | N/A | 130 | Zhejiang UniversityOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT00949819 | Active Surveillance for Cancer of the Prostate (ASCaP)(ASCaP) | recruiting | — | 462 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT06492122 | Study With [225Ac]Ac-FL-020 in mCRPC Participants(ProTACT) | recruiting | Phase 1 | 50 | Full-Life Technologies UK LimitedINDUSTRY | 4 | May 26, 2026 | clinicaltrials |
| NCT06508567 | Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era(SHAPE-PSMA) | recruiting | N/A | 20 | University Health Network, TorontoOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT06574880 | STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer(STARLiT) | recruiting | Phase 1 / Phase 2 | 45 | Angela Y. Jia, MD PhDOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT07605936 | Frailty in Older Adults With Prostate Cancer: a Prospective Cohort Study | recruiting | — | 80 | University of LimerickOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT03151629 | International Registry for Men With Advanced Prostate Cancer (IRONMAN)(IRONMAN) | recruiting | — | 5,000 | Prostate Cancer Clinical Trials ConsortiumOTHER | 15 | May 22, 2026 | clinicaltrials |
| NCT05225428 | Video Education With Result Dependent dIsclosure(VERDI) | recruiting | N/A | 1,020 | Dana-Farber Cancer InstituteOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT05931419 | High-Risk prostatE Cancer radiatiOn Versus surgERy(RECOVER) | recruiting | — | 837 | Comprehensive Cancer Centre The NetherlandsOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07189403 | A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer | recruiting | Phase 1 | 40 | Daiichi SankyoINDUSTRY | 3 | May 22, 2026 | clinicaltrials |
| NCT07427043 | Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)(ROPES) | recruiting | Phase 3 | 300 | Brigham and Women's HospitalOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07468903 | Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer | recruiting | N/A | 45 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07196488 | Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses | recruiting | N/A | 60 | National Taipei University of Nursing and Health SciencesOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT03933670 | Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance | recruiting | Phase 2 | 60 | University of California, San FranciscoOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07541911 | A Study to Evaluate the Performance of Confocal Microscopy to Detect Positive Margins During Radical Prostatectomy(LaserSAFE) | recruiting | N/A | 693 | University College, LondonOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT04472338 | Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study | recruiting | — | 450 | University of WashingtonOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT05627219 | Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network | recruiting | — | 30 | Thomas Jefferson UniversityOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT06177093 | Pilot Study of Dose Escalation in Prostate Radiotherapy Using the MR-Linac (DESTINATION-MRL)(DESTINATION-MR) | recruiting | N/A | 20 | Sunnybrook Health Sciences CentreOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT06862856 | Flotufolastat F 18 PET in Men With Very Low PSA Recurrence | recruiting | — | 50 | Massachusetts General HospitalOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07093801 | Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer | recruiting | — | 300 | Novartis PharmaceuticalsINDUSTRY | 1 | May 15, 2026 | clinicaltrials |
| NCT07244341 | A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC) | recruiting | Phase 1 | 60 | Daiichi SankyoINDUSTRY | 4 | May 15, 2026 | clinicaltrials |
| NCT07476001 | Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC | recruiting | Phase 2 | 12 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT05413850 | Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection | recruiting | Phase 1 / Phase 2 | 82 | Blue Earth Therapeutics LtdINDUSTRY | 5 | May 14, 2026 | clinicaltrials |
| NCT06733350 | Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance | recruiting | Phase 4 | 600 | Roswell Park Cancer InstituteOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT06673329 | Brodalumab in the Treatment of Immune-Related Adverse Events | recruiting | Phase 1 | 11 | Brian Henick, MDOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT06523634 | Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.(STEREOBED) | recruiting | N/A | 284 | Jules Bordet InstituteOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT06787053 | Selecting Hypoxic Tumours for Treatment Modification(SELECT) | recruiting | — | 30 | University of ManchesterOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT06879041 | A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 1 | 136 | AstraZenecaINDUSTRY | 3 | May 12, 2026 | clinicaltrials |
| NCT07580196 | Bilateral Versus Unilateral Lymph Node Dissection in High-Risk Prostate Cancer (BALANCE)(BALANCE) | recruiting | N/A | 820 | University of Turin, ItalyOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT05645510 | LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study(LONGEVITI) | recruiting | — | 75 | University of AlbertaOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT04035642 | Single-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT II)(PROSINT II) | recruiting | N/A | 200 | Fundacao ChampalimaudOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT04986423 | ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 2 | 200 | Zenith EpigeneticsINDUSTRY | 2 | May 8, 2026 | clinicaltrials |
| NCT06011499 | Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE(iLIVE) | recruiting | N/A | 250 | OHSU Knight Cancer InstituteOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT07384416 | QL1706 Plus Lenvatinib in Previously Treated Penile Cancer | recruiting | Phase 2 | 47 | Sun Yat-sen UniversityOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT07414940 | ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium(ACT-RESoLUTE) | recruiting | Phase 1 / Phase 2 | 60 | University College, LondonOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT03880422 | Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer | recruiting | N/A | 50 | Roswell Park Cancer InstituteOTHER | 1 | May 7, 2026 | clinicaltrials |
| NCT07572760 | Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer. | recruiting | N/A | 66 | University of AlicanteOTHER | 1 | May 7, 2026 | clinicaltrials |
| NCT03819101 | Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer(PEACE-4) | recruiting | Phase 3 | 1,210 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 6 | May 6, 2026 | clinicaltrials |
| NCT04868604 | 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)(SECuRE) | recruiting | Phase 1 / Phase 2 | 54 | Clarity Pharmaceuticals LtdINDUSTRY | 1 | May 6, 2026 | clinicaltrials |
| NCT06239194 | Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 285 | ModeX Therapeutics, An OPKO Health CompanyINDUSTRY | 1 | May 6, 2026 | clinicaltrials |
| NCT07504835 | GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer | recruiting | N/A | 150 | OHSU Knight Cancer InstituteOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT07568613 | Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Prostate in Men With Newly Diagnosed Prostate Cancer(PRIDE2-PC) | recruiting | N/A | 50 | German Oncology Center, CyprusOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT05125016 | A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer | recruiting | Phase 1 / Phase 2 | 228 | Regeneron PharmaceuticalsINDUSTRY | 1 | May 5, 2026 | clinicaltrials |
| NCT06616155 | Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 1 / Phase 2 | 20 | University of Michigan Rogel Cancer CenterOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT07354919 | Axelopran for Advanced Cancer in Patients Receiving Opioids(AxeCan) | recruiting | Phase 2 | 34 | HealthPartners InstituteOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT05948657 | Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr(ESCAPE) | recruiting | N/A | 200 | Weill Medical College of Cornell UniversityOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT06193369 | Digital Peer Navigation for Adolescents and Young Adults With Cancer | recruiting | N/A | 138 | University Health Network, TorontoOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT06429813 | Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006) | recruiting | N/A | 24 | Paul ViscuseOTHER | 1 | May 4, 2026 | clinicaltrials |
Data updated 23 days agoSource updated May 28, 2026source: clinicaltrials